Phase
Condition
Genital Herpes
Herpes Simplex Infections
Cold Sores (Herpes Labialis Infections)
Treatment
N/AClinical Study ID
Ages 12-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Outpatient males or females 12 to <18 years of age
- General good health with a documented history typical for recurrent herpes labialis
- Prodromal symptoms or active lesions suggestive of a recurrent episode of herpeslabialis (i.e. having had cold sores in the past) , with onset not exceeding 24 hoursuntil the time of study drug administration
- Adolescents participating in Pharmacokinetics (PK) part of the study may beenrolled without an active herpes labialis recurrence or with onset ofsigns/symptoms of a recurrent herpes labialis episode longer than 24 hours beforestudy drug administration, All adolescents participating in the pharmacokineticsassessments must fast for at least 8 hours prior to Visit 1 and be willing tofast for an additional 2 hours after study drug administration
Exclusion
Exclusion Criteria:
- Use of other investigational drugs within 30 days of enrollment
- History of hypersensitivity to famciclovir or penciclovir
- Inability to swallow tablets
- Body weight less than 40 Killograms (kg)
- History of malabsorption, unless a condition like celiac disease is stable and wellcontrolled, previous gastrointestinal surgery or radiation therapy that could affectdrug absorption or metabolism, or any condition that could interfere with drugabsorption, distribution, metabolism, or excretion
- Known renal insufficiency (calculated creatinine clearance <60 [Milliliters/Minutes]mL/min)
- Known severe hepatic impairment (Child-Pugh Class C)
- Significant skin disease such as atopic dermatitis or eczema that would interfere withassessment of oral/labial lesions
- Known to be immunocompromised or are receiving systemic or using topicalimmunosuppressive agents (including corticosteroids, tacrolimus and picrolimus) within 30 days of enrollment
- Concomitant use of probenecid
- Pregnant or nursing (lactating) females
- Females of child-bearing potential, UNLESS they are using two birth control methods.The two methods can be a double barrier method or a barrier method plus a hormonalmethod.
Study Design
Study Description
Connect with a study center
Women's Health Care at Frost Street
San Diego, California
United StatesSite Not Available
Children's Memorial Hospital
Chicago, Illinois 60614
United StatesSite Not Available
Medisphere Medical Research Center, LLC
Evansville, Indiana 47714
United StatesSite Not Available
Clayton Medical Research
Saint Louis, Missouri 63117
United StatesSite Not Available
Clayton Medical Research
St. Louis, Missouri 63117
United StatesSite Not Available
Rochester Clinical Research, Inc.
Rochester, New York
United StatesSite Not Available
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229
United StatesSite Not Available
University Hospitals Case Medical Center
Cleveland, Ohio 44106
United StatesSite Not Available
Westover Heights Clinic
Portland, Oregon 97210
United StatesSite Not Available
Primary Physicians Research, Inc
Pittsburgh, Pennsylvania
United StatesSite Not Available
Texas Children's Hospital
Houston, Texas 77030
United StatesSite Not Available
R/D Clinical Research
Lake Jackson, Texas 77566
United StatesSite Not Available
R/D Clinical Research, Inc
Lake Jackson, Texas 77566
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.